Center of Excellence in Genomic Science to be Established in Chicago | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Center of Excellence in Genomic Science to be Established in Chicago

October 21, 2016
by Rajiv Leventhal
| Reprints

The National Human Genome Research Institute has awarded $10.6 million over five years for the establishment of a new research center in Chicago to advance genomic science.

Chicago’s first Center of Excellence in Genomic Science—one of only seven such centers in the U.S.— will be led by University of Chicago scientists who will aim to develop new and innovative technologies to decode RNA modifications, the next layer of gene expression control, University of Chicago said in an announcement.

Indeed, the center, will create new technologies for studying how RNA—the middle step between DNA and protein—is regulated by chemical modifications inside cells. These modifications, present in almost every eukaryotic organism and cell, are critical in development and disease, including neurological disorders and cancer, officials attest.

In cells, DNA encodes the recipe for producing proteins, the building blocks of life. The middleman is RNA, a copy of a DNA segment that travels to ribosomes, where proteins are constructed. While much research has focused on DNA modifications that stimulate or inhibit this gene expression, the impact of RNA modifications in gene expression received scant attention until 2011.

But, there have been limitations of current approaches for finding and mapping RNA modifications, as well as determining their roles in development and disease. As such, the new center’s primary mission will be to develop new methods and sequencing technologies that enable fundamental and clinical investigations of various chemical marks on RNA or epitranscriptomes, facilitating the discovery and characterization of new “switches” on the control panel of gene expression in different biological processes and disease.

The new center will pursue new procedures for finding and mapping RNA modifications, as well as manipulating their functions to observe their effects upon RNA metabolism and gene expression. The team also will develop new bioinformatics methods for analyzing RNA modifications. Collaborations with researchers at Johns Hopkins University and Emory University will apply these new technologies to studies of human neurodevelopment and neurogenesis, to examine the role of RNA modifications in brain development and disease, officials said.

“In the next five years, both the NIH and us envision that this CEGS will invent new technologies to really impact fundamental biology and human health,” said Chuan He, Ph.D., the John T. Wilson Distinguished Service Professor in Chemistry and Howard Hughes Medical Institute Investigato “RNA modifications are one of the major ways to affect gene expression regulation; they intersect with different biological pathways and impact essential and fundamental biological processes. So we want to solve the current bottleneck problems of their detection and sequencing.”

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.

Analysis: Healthcare Ransomware Attacks Decline in First Half of 2018

In the first half of 2018, ransomware events in major healthcare data breaches diminished substantially compared to the same time period last year, as cyber attackers move on to more profitable activities, such as cryptojacking, according to a new report form cybersecurity firm Cryptonite.